8 
II-A-l-f. Statement Regarding Training and Continuing Compliance . 
The appropriate institutional official must submit a statement that the 
institution agrees to accept responsibility for the training of all 
laboratory workers involved in the project, and that the IBC will ensure 
conpliance with the Guidelines throughout the duration of the project. 
II-A-l-g. Signatures . The signatures of the Principal 
Investigator, the IBC chairperson, and the institutional official(s) are 
required. The Institution may designate the IBC chairperson as the 
responsible institutional official, except for projects requiring prior 
approval by NIH (see Section I-B). 
II-A-l-h. Date of MUA . For future reference, the date of the MUA 
will be the date of the institutional official's signature. 
II-A-2. MJAs for Recombinant DMA Research at Multiple Sites . When 
research at multiple sites is proposed, the MUA must specify where each 
portion of the project will be carried out. When research is proposed 
at sites governed by other than the applicant Institution, signatures of 
the appropriate officials at both the applicant Institution and the 
Institution(s) where the recombinant DMA research is to be conducted 
are required. The signatures shall indicate that the IBCs of each of 
the Institution(s) where the research is to be performed have given the 
certification and/or assurance required in Section II-A-l-e of the MUA. 
[ 71 ] 
